COMMUNIQUÉS West-GlobeNewswire

Discovery Point Retreat Offers Drug and Alcohol Rehabilitation in Texas

20/02/2018 - 13:00

WAXAHACHIE, Texas, Feb. 20, 2018 (GLOBE NEWSWIRE) -- In an ongoing effort to help combat the substance abuse epidemic affecting the United States, Niznik Behavioral Health introduces Discovery Point Retreat, a drug and [...]

Melinta Therapeutics’ Commercial Partner Eurofarma Laboratórios Submits Marketing Authorization Application for Delafloxacin in Argentina

20/02/2018 - 13:00

NEW HAVEN, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today [...]

Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders

20/02/2018 - 13:00

Wave to receive at least $230 million, including $110 million in upfront cash, $60 million in equity investment and at least $60 million in research support Takeda to receive option to co-develop and co-commercialize [...]

Urgent besoin de donneurs d’ici la semaine de relâche

20/02/2018 - 13:00

OTTAWA, 20 févr. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang lance un appel urgent au don de sang. L’organisation a besoin de 35 000 donneurs d’ici le congé du printemps pour s’assurer que tous les patients [...]

AxoGen, Inc. to Present at Canaccord Genuity Musculoskeletal Conference

20/02/2018 - 13:00

ALACHUA, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, [...]

Amunix announces XTEN® and ProTIA technology licensing agreement with Celgene

20/02/2018 - 13:00

MOUNTAIN VIEW, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. (Amunix), a biopharmaceutical company focused on the discovery and development of novel immuno-oncology therapeutics, is pleased to announce [...]

Recro Pharma Announces Publication of Supportive Phase II IV Meloxicam Bunionectomy Data in the Journal of Pain Research

20/02/2018 - 13:00

MALVERN, Pa., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit

20/02/2018 - 12:55

ANN ARBOR, Mich., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V: ZOM ) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced its [...]

Capital Senior Living Corporation Announces That Jeremy D. Falke Has Joined as Senior Vice President of Human Resources

20/02/2018 - 12:45

DALLAS, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, today announced that Jeremy D. Falke has [...]

Two Additional Collaborative Human Studies on NIAGEN® with the University of Cambridge and the University of Washington Now Registered on Clinical-trials.gov.

20/02/2018 - 12:30

IRVINE, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that two new [...]

Dynavax Secures $175 Million in Non-Dilutive Debt Financing

20/02/2018 - 12:30

Proceeds to be Used to Commercialize HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] in United States and Advance Company’s Immuno-Oncology Product Candidates Company Deploying HEPLISAV-B Field Sales Team [...]

Transactions in relation to share buyback program

20/02/2018 - 12:23

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Company Announcement No. 6/2018

20/02/2018 - 12:00

http://prlibrary-eu.nasdaq.com/Resource/Download/6a9bc9ba-416d-4113-9353-50457c40d5cb

BioCryst to Announce Fourth Quarter and Full Year 2017 Financial Results on February 27

20/02/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today that its fourth quarter and full year 2017 financial results will be reported on Tuesday, [...]

Comfort Recovery Now In-Network with Humana, Aetna, and Beacon Health Options

20/02/2018 - 12:00

NORTH MIAMI, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Comfort Recovery, a national provider of drug and alcohol recovery treatment in North Miami, recently contracted with Humana, Aetna, and Beacon Health Options, three [...]

Vical Initiates Phase 2 Trial of VL-2397 Antifungal for Invasive Aspergillosis

20/02/2018 - 12:00

SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) announced today the initiation of a Phase 2 trial of the Company’s VL-2397 novel antifungal compound. The multicenter, open label [...]

Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, M.D., to Medical Advisory Board

20/02/2018 - 11:30

LOS ANGELES, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR ) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutics that modulate the gut microbiome to treat [...]

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases

20/02/2018 - 11:00

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases Alliance aims to shorten the often multi-year journey that patients and families endure before being [...]

Photocure ASA: Presentation of the fourth quarter and full year 2017 results

20/02/2018 - 10:54

Photocure will present its fourth quarter and full year 2017 report on Tuesday 27 February 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be [...]